DTL Recombinant antibody

DTL Recombinant Antibody for IF, FC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

Human

Applications

IF, FC, ELISA

Conjugate

Unconjugated

CloneNo.

230144C9

Cat no : 83107-1-RR

Synonyms

CDT2, CDW1, DCAF2, Denticleless protein homolog, DTL, L2DTL, RAMP



Tested Applications

Positive IF detected inHeLa cells
Positive FC detected inHeLa cells

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)IF : 1:200-1:800
Flow Cytometry (FC)FC : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

83107-1-RR targets DTL in IF, FC, ELISA applications and shows reactivity with Human samples.

Tested Reactivity Human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen DTL fusion protein Ag33391
Full Name denticleless homolog (Drosophila)
Calculated Molecular Weight 730 aa, 79 kDa
GenBank Accession NumberBC033540
Gene Symbol DTL
Gene ID (NCBI) 51514
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

CDT2, also named as L2DTL or RAMP, is one of the substrate receptors of the Cullin Ring Ubiquitin Ligase 4 that targets for ubiquitin mediated degradation a number of substrates, such as CDT1, p21 and CHK1, involved in the regulation of cell cycle and survival. CDT2 overexpression was reported in breast (PMID: 18542055), gastric (PMID: 19672268) and ovarian carcinomas (PMID: 23995842) and rhabdomyosarcomas (PMID: 19235922) and associated with the aggressiveness of hepatocellular carcinomas (PMID: 17106265).

Protocols

Product Specific Protocols
IF protocol for DTL antibody 83107-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols